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Summary
Compared to Caucasians, South East Asian babies have more fre-
quently jaundice, requiring phototherapy. This is partly due to the high
prevalence of· G6PD deficiency and other genetically determined
haematological abnormalities. If no underlying cause is found, these
babies tend to be labelled as having 'excessive' physiological jaundice
or alternatively idiopathic pathological jaundice.
It is likely however that jaundice in newborns is a complex interplay
between multiple genetic and environmental risk factors. Often more
than one risk factor may be present such as in G6PD deficiency where
recently it was discovered that neonatal jaundice is often only not ac-
companied by haemolysis. An association was found with Gilbert syn-
drome
One relatively recently described risk factor in the South East Asian
population is the presence of point mutations in the coding regions for
the gene of the uridine diphosphate glucuronyl transferase enzyme. These
point mutations may decrease the activity of the enzyme responsible for
glucuronidation of the indirect bilirubin just slightly. This can cause
jaundice that is really excessive in babies with other risk fact'ors.
Neonatal jaundice is most likely a real multifactorial pathological
event based on many genetic and environmental factors. In future we
will look more at a combination of risk factors for jaundice, rather than
just attributing the jaundice to one risk factor alone. The number of
babies labelled as 'excessive physiologic jaundice' or idiopathic jaun-
dice might decrease significantly in the near future.
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Introduction
Neonatal jaundice is the most common condition requiring medical
attention in the newborn period. It has been classically attributed to a
number of more or less common causes. The causes are classically
divided in two main groups. The first group is comprising of conditions
associated with an increase in break down of red blood cells such as
Rhesus incompatibility, ABO blood group incompatibility, G6PD defi-
ciency, birth trauma and polycythaemia. A second group consists of
conditions in which the excretion of bilirubin is diminished such as
breast feeding jaundice, breast milk jaundice, Gilbert syndrome or the
more severe Crigler Najjar syndrome.
Many babies however get jaundice without any of the above causes
being identified. In these babies the term physiological jaundice is often
applied. Even if bilirubin levels go up in the phototherapy range it has
been called 'excessive physiological jaundice' and ifit approaches exchange
transfusion level it tends to. be called idiopathic pathological jaundice.
In the latest decade and especially since the advent of genomics
there have been some remarkable discoveries that may change our per-
ception of the pathophysiology of neonatal jaundice thoroughly.' In-
stead of attributing neonatal jaundice to a single condition as is classi-
cally, done, we may realise in the near future that the presence of one
risk factor for NNJ is often not enough to cause severe or even mod-
erately severe NNJ. New nsk factors have been identified and an asso-
ciation of several risk factors may be often present 2. J so that it may
become more appropriate to count the number of risk factors for the
development of neonatal jaundice in a particular child rather than attrib-
uting the jaundice to· one or another risk factor.
G6PD Deficiency
G6PD deficiency is among the most common causes of neonatal
jaundice in many populations. G6PD deficiency can lead to severe
haemolytic crises in older children and adults after exposure to oxidant
stresses (favism). That is why it was classically believed that the neonatal
jaundice, associated with G6PD deficiency, is due to haemolysis as
well. There are indeed very occasionally babies with G6PD deficiency
having real favism-like presentations:~ In these babies a known oxidant
stress or infection can often be identified. Most babies however with
G6PD deficiency and neonatal jaundice present quite differently and
have a gradual onset of jaundice, often only becoming visible on day
3 of life. In this latest kind of presentation, usually no obvious signs of
haemolysis can be found.
Multiple studies have been undertaken looking at the presence of
haemolysi,s in G6PD deficient neonates with jaundice. Measurement of
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CO-haemoglobin (COBb) is a good way to assess bilirubin production
and haemolysis since in the production of bilirubin, protoheme is split,
releasing CO which is produced in equimolar quantities with bilirubin.5
Except for one study6 done in a Nigerian population, most studies measuring
CO production in G6PD deficient neonates 7,8.9 showed only a very
slight increase in CO production compared to G6PD normal controls
but CO production was found to be. completely similar in those G6PD
deficient neonates with and those without jaundice.
Furthennore Kaplan 10 has shown quite conclusively that the levels of
direct bilirubin were lower in G6PD deficient neonates with jaundice
than in G6PD normal neonates with jaundice, indirectly indicating that
there may be also a decrease in glucuronidation of bilirubin in those
G6PD deficient neonates with jaundice. Further genetic analysis2 of the
same study population showed indeed a high prevalence of polymor-
phism of the promotor region of the UGTIAI gene. (Gilbert Syndrome).
The currently available data suggest that the majority of babies with
G6PD deficiency and neonatal jaundice do not have severe haemolysis.
They have rather a very mild haemolysis that by itself may be not
severe enough to cause jaundice but a combination of G6PD deficiency
and other risk factors may be necessary to make the infants jaundiced
The molecular basis of G6PD deficiency has been studied in the
Malaysian population and it was discovered that the genotype is hetero-
geneous in Malays as well as in the Chinese race I1 - 1J •
ABO Incompatibility
ABO incompatibility is another major cause ofjaundice in the neonatal
period. Often the babies get jaundice on day one of life. The direct
Coombs test is 'falsely' negative in up to 70 % of the cases. This means
that in up to 70 % of cases of ABO incompatibility with early onset
jaundice we fail to show the presence of maternal antibodies against the
blood group of the baby. This may be due to low titers of antibodies or
to the immature expression on the red blood cells of the babies. Often
we fail to show a drop in haemoglobin levels and if the expression of
the blood group is so immature in many red blood cells, othec factors
than haemolysis alone may playa role in the pathophysiology of ABO
incompatibility associated neonatal jaundice. Kaplan found that in a
Jewish population, Gilbert syndrome was a determining factor for jaun-
dice related to ABO incompatibility 3
Other 'VeIl Known Causes of Jaundice
A similar reasoning may be made for most of the other. well known
causes of jaundice. Some children with mild birth trauma develop se-
vere jaundice while others with sever.e subaponeurotic haemorrhage do
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not develop jaundice. Similar observations can be made for polycythae-
mia, breastfeeding jaundice and others. The subsequent discussion will
cover some of such additional risk factors.
Gilbert Disease
This is an autosomal dominant condition in which a polymorphism
of the promotor region of the UGTIAI gene is observed. This disease
occurs with a high frequency in some Caucasian populations. It can
present in the neonatal period with jaundice and patients may get mild
jaundice in episodes of stress. The babies with only this genetic variant
and no other risk factors for jaundice may not get jaundice but those
with other risk factors may be the ones who get jaundice. 14
Other Mutations in the UGTIAI Gene
A large variety of other mutations have been described in populations
of different ethnic origin. However in the Southeast Asian population
where jaundice has a very high incidence, only recently some attention
has been given to the molecular analysis of the UGTIAI gene. A first
mutation has been described in the Thai population 15 and has subse-
quently been found in a relatively high proportion of Malay babies with
jaundiceJ6 • .
Two other novel mutations in the same gene have been recently
described in Malaysian babies 17 • These could be either real mutations or
polymorphisms. In either case, it could be predisposing the neonates to
develop jaundice if other risk factors are present. By itself it might
disturb the bilirubin metabolism rather mildly and not cause severe
jaundice
Other Potential Molecular Explanations of the NNJ
There are numerous other enzymes or transport proteins involved in
the metabolism of bilirubin. There is the transport protein of bilirubin
across the liver cells. There are also the heme oxidase and the b[liverdin
reductase. In each of these, there may be a genetic or environmental
factor interfering enough with the metabolism of bilirubin to cause jaundice
or be at least a significant risk factor worsening jaundice in the presence
of other risk factors, Examples of these include the fact that some stress
hormones such as corticoids or some endotoxins could increase the
activity of biliverdin reductase and stimulate as such the bilirubin pro-
duction 1&. .
There is a vast field for future research in order to elucidate fully the
pathophysiology of neonatal jaundice .
Kuala Lumpur, Malaysia, April 14-18, 2004 93
Conclusion
Results of recent studies and developments in molecular biology are
leading to newer insights in the pathophysiology of neonatal jaundice.
Often significant jaundice may not be attributable to just one cause but
neonatal jaundice has most likely a truly multifactorial causality. As our
knowledge in the bilirubin metabolism on the molecular level advances,
we may meet less and less 'excessive physiological jaundice' or idi-
opathic pathological jaundice. A better knowledge of all risk factors
involved will lead to a more effective prevention of severe neonatal
jaundice through identification and early treatment of high-risk cases.
References
1. Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubi-
naemia in the era of genomics. Semin Neonatal, 7(2): 143-152,2002.
2. Kaplan M, Renbau.Tll P, Levy-Lahad E, Hammerman C, et a1. Gilbert syn-
drome and glucose-6-phosphate dehydrogenase deficiency: a dose-depend-
ent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl
Acad Sci USA. 94(22):12128-12132,1997.
3. Kaplan M, Hammerman C, Renbaum P, Klein G, et a1. Gilbert's syndrome
and hyperbilirubinaernia in ABO-incompatible neonates. Lancet, 356(9230):652-
653,2000. :
4. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency:
a potential source of severe neonatal hyperbilirubinaemia and kernicterus.
Semin Neonatal, 7(2): 121-128,2002.
5. Engel RR, Rodkey FL, Krill CE, Jr. Carboxyhemoglobin levels as an index
of hemolysis. Pediatrics, 47(4):723-730,1971.
6. Slusher TM, Vretnan HJ, McLaren DW, Lewison LJ, et a1. Glucose-6-
phosphate dehydrogenase deficiency and carboxyhemoglobin concentra-
tions associated with bilirubin-related morbidity and death in Nigerian in-
fants. J Pediatr, 126(1):102-108,]995.
7. Kaplan M, Vreman HJ, Hammerman C, Leiter C, et al. Contribution of
haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydro-
genase deficient neonates. Br J Haemato!, 93(4):822-827,1996.
8. Seidman DS, Shiloh M, Stevenson DK, Vreman HJ, et a1. Role of hemolysis
in neonatal jaundice associated with glucose-6 phosphate dehydrogenase
deficiency. J Pediatr. 127(5):804-806,1995.
9. Van Rostenberghe H, Selamah G, Nik Zainal A, Nishio H. Poor correlation
between hemolysis and neonatal jaundice in Malaysian G6PD-deficicnt babies.
Submitted for publication to Pediatr In!
10. Kaplan M, Muraca M, Hammerman C, Vilei MT, et a1. Unconjugated and
conjugated bilirubin pigments during perinatal development. V. Effect of
phototherapy on serum conjugated bilirubin in hyperbilirubinemic neonates.
Bio! Neonate. 73(3): 155-160,1998.
11. YusoffNM, Shirakawa T, Nishiyama K, Ghazali S, et al. Molecular hetero-
geneity of glucose-6-phosphate dehydrogenase deficiency in Malays in
Malaysia. Int J Hemato!, 76(2): 149-152,2002.
94 13th Congress oj the Federation ojAsia and Oceania Perinatal Societies
12. Ainoon 0, Joyce J, Boo NY, Cheong SK. et al. Glucose-6-phosphate de-
hydrogenase (G6PD) variants in Malaysian Chinese. Hum Mutat, 14(4):
352,1999.
13. Ainoon 0, Yu YH, Amir Muhriz AL, Boo NY, et al. Glucose-6-phosphate
dehydrogenase (G6PD) variants in Malaysian Malays. Hum Mutat,
21(1): 101,2003.
14. Ulgenalp A, Duman N, Schaefer FV, Whetsell L, et al. Analyses of poly-
morphism for UGTI * 1 exon 1 promoter in neonates with pathologic and
prolonged jaundice. Bioi Neonate, 83(4):258-262,2003.
15. Sutomo R, Laosombat V, Sadewa AH, Yokoyama N, et al. Nove! missense
mutation of the UGTIA1 gene in Thai siblings with Gilbert's syndrome.
Pediatr Int, 44(4):427-432,2002.
16. Sutomo R, Norlelawati A, Yusoff N, Van Rostenberghe H et al. Screening
for G71R mutation of the UGT1A1 gene in the Javanese-Indonesian and
Malay-Malaysian populations. Pediatr Int, 46(5), 2004
17. Norlelawati A, Van Rostenberghe H,,-Sutomo R, Matsuo M. et al. Novel
Missense Mutations 964A-.7G and 1477G-.7C, in the UGT1Al Gene in
Malay Babies with Early Onset of Severe Neonatal Jaundice. Submitted for
publication to Annals Med Gen
18 Dennery PA. The biology ofheme oxygenase during development. Neoreviews,
2: e67-e73, 2001
